Dr. A. Kharlamov is a senior cardiologist and physician-scientist with 28 years of clinical experience in cardiology. He has served as a Consultant Physician since 2007 and became a Board-Certified Cardiologist through postgraduate training in 2010. Since 2007, he has also led bench-to-bedside research in interventional cardiology, focusing on cardiovascular imaging, vascular biology, and pathology.

His work includes the research, development, and translation of advanced medical technologies such as:

• Artificial intelligence and machine learning-powered cardiovascular imaging software

• Bioresorbable scaffolds and stents

• Nanotechnology-based medical devices

Dr. Kharlamov earned his Doctor of Medicine (cum laude) from Ural State Medical University (Yekaterinburg, Russia) in 2005. After completing his internship in internal medicine in 2007 at the Ural Institute of Cardiology, he began his dual career as a physician and researcher. He completed a doctoral program (C.Sc., ABD) in cardiology from 2008 to 2011 at his alma mater.

From 2007 to 2009, he held research fellowships at leading Dutch institutions including UMC St. Radboud (Nijmegen), UMCG (Groningen), and Erasmus MC (Rotterdam).

Dr. Kharlamov is the author of over 60 publications and European Commission grant proposals, and he has received several national and international awards for his scientific work.

He holds the following professional fellowships:

• FESC (Fellow of the European Society of Cardiology, 2018)

• FACC (Fellow of the American College of Cardiology, 2019)

• FEACVI (Fellow of the European Association of Cardiovascular Imaging, 2020)

​

Publications:
h-index = 9. The publication profile is available in PubMed (akharlamov@orcid), ORCiD (0000-0003-4631-1261), ResearcherID/ Web of Science (I-3692-2015), and Scopus (56721449700). The editorial/ reviewer profile (Local editorial board member in EuroIntervention in 2011-2013, member of the International Editorial Board in European Heart Journal in 2013-2015, consulting editor in both Cardiovascular Diagnosis and Therapy in 2013-2017, and International Journal of Nanomedicine in 2013-2019), member of the Editorial Board in World Journal of Cardiology (in 2018-2023) and BMC: Cardiovascular Disorders (since 2020) is available in Publons/ Web of Science (publons.com/a/1136995/). We do not collaborate with ResearchGate.

​

Memberships:
European Society of Cardiology - ESC (since 2006; FESC since 2018; FEACVI since 2020; a Treasurer of the ESC Council for Cardiology Practice with a mandate in 2022-2024), American College of Cardiology - ACC (since 2009; FACC since 2019), American Heart Association - AHA (since 2009), International Society for Stem Cell Research - ISSCR (since 2009), International Society of Nephrology - ISN (since 2009), European Society for Nanomedicine - ESNM (since 2011), The Society for Cardiovascular Angiography and Interventions - SCAI (since 2017), World Sleep Society - WSS (since 2018), The British Society for Nanomedicine - BSN (since 2018), Royal College of Physicians of London - RCP (since 2019), International Society for Cardiovascular Translational Research - ISCTR (since 2019), American Association for the Advancement of Science - AAAS (since 2019), Society of Cardiovascular Computed Tomography - SCCT (since 2019).